Evolus (EOLS) Misses Q4 EPS by 9c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts EOLS Hot Sheet
Join SI Premium – FREE
Evolus (NASDAQ: EOLS) reported Q4 EPS of ($0.21), $0.09 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $60.99 million versus the consensus estimate of $60.19 million.
GUIDANCE:
Evolus sees FY2024 revenue of $255-265 million, versus the consensus of $263.5 million.
For earnings history and earnings-related data on Evolus (EOLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- Myomo names new chief commercial officer effective October 2026
- Cryo-Cell International, Inc. (CCEL) Tops Q3 EPS by 13c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
